In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Castle Biosciences Inc’s stock clocked out at $27.96, up 3.59% from its previous closing price of $26.99. In other words, the price has increased by $3.59 from its previous closing price. On the day, 0.68 million shares were traded. CSTL stock price reached its highest trading level at $28.56 during the session, while it also had its lowest trading level at $26.95.
Ratios:
To gain a deeper understanding of CSTL’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.27. For the most recent quarter (mrq), Quick Ratio is recorded 7.92 and its Current Ratio is at 8.12. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 14, 2023, initiated with a Buy rating and assigned the stock a target price of $25.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $54.
On January 07, 2022, Stephens started tracking the stock assigning a Overweight rating and target price of $59.Stephens initiated its Overweight rating on January 07, 2022, with a $59 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when BRADBURY DANIEL sold 7,883 shares for $26.65 per share. The transaction valued at 210,058 led to the insider holds 8,550 shares of the business.
Stokes Frank sold 10,000 shares of CSTL for $256,997 on Aug 07 ’24. The Chief Financial Officer now owns 30,823 shares after completing the transaction at $25.70 per share. On Aug 12 ’24, another insider, Daniel Bradbury, who serves as the Officer of the company, bought 15,750 shares for $26.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CSTL now has a Market Capitalization of 775520896 and an Enterprise Value of 541022784. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.70 while its Price-to-Book (P/B) ratio in mrq is 1.83. Its current Enterprise Value per Revenue stands at 1.881 whereas that against EBITDA is -202.554.
Stock Price History:
Over the past 52 weeks, CSTL has reached a high of $28.22, while it has fallen to a 52-week low of $12.07. The 50-Day Moving Average of the stock is 26.82%, while the 200-Day Moving Average is calculated to be 30.09%.
Shares Statistics:
It appears that CSTL traded 379.57K shares on average per day over the past three months and 637630 shares per day over the past ten days. A total of 27.41M shares are outstanding, with a floating share count of 25.90M. Insiders hold about 6.63% of the company’s shares, while institutions hold 88.05% stake in the company. Shares short for CSTL as of 1722384000 were 1402472 with a Short Ratio of 3.69, compared to 1719532800 on 1171967. Therefore, it implies a Short% of Shares Outstanding of 1402472 and a Short% of Float of 5.21.
